1. Han SS, Chung EJ. Accuracy of intraocular lens power estimation in eyes undergoing phacovitrectomy for proliferative diabetic retinopathy. J Korean Ophthalmol Soc. 2015; 56:737–744.
Article
2. Choi AY, Yeo Y, Kim YC. Phacovitrectomy versus phacoemulsification after vitrectomy for rhegmatogenous retinal detachment repair. J Korean Ophthalmol Soc. 2015; 56:357–364.
Article
3. Canan H, Sizmaz S, Altan-Yaycioğlu R. Surgical results of combined pars plana vitrectomy and phacoemulsification for vitreous hemorrhage in PDR. Clin Ophthalmol. 2013; 7:1597–1601.
Article
4. Park SP, Ahn JK, Lee GH. Morphologic changes in the anterior segment after phacovitrectomy for proliferative diabetic retinopathy. J Cataract Refract Surg. 2009; 35:868–873.
Article
5. Wahab S, Das Hargun L. Combined phacoemulsification, vitrectomy and endolaser photocoagulation in patients with diabetic retinopathy and cataract. J Coll Physicians Surg Pak. 2014; 24:736–739.
6. Yang Y, Zhang J, Yan H. Comparison of combined and sequential surgery for proliferative diabetic retinopathy: a single surgeon study. PLoS One. 2014; 9:e108933.
Article
7. Mirza SA, Alexandridou A, Marshall T, Stavrou P. Surgically induced miosis during phacoemulsification in patients with diabetes mellitus. Eye (Lond). 2003; 17:194–199.
Article
8. Mojumder DK, Patel S, Nugent K, et al. Pupil to limbus ratio: Introducing a simple objective measure using two-box method for measuring early anisocoria and progress of pupillary change in the ICU. J Neurosci Rural Pract. 2015; 6:208–215.
9. Martín-Moro JG, de la, Sanz FG. Conceptual advantages of using pupil to limbus ratio over absolute pupil diameter. J Neurosci Rural Pract. 2015; 6:625–626.
Article
10. Hreidarsson AB. Pupil size in insulin-dependent diabetes. Relationship to duration, metabolic control, and long-term manifestations. Diabetes. 1982; 31(5 Pt 1):442–448.
Article
11. Mirshahi A, Djalilian A, Rafiee F, Namavari A. Topical administration of diclofenac (1%) in the prevention of miosis during vitrectomy. Retina. 2008; 28:1215–1220.
Article
12. Yu AY, Guo H, Wang QM, et al. Pupil dilation with intracameral epinephrine hydrochloride during phacoemulsification and intraocular lens implantation. J Ophthalmol. 2016; 2016:4917659.
Article
13. Huber MJ, Smith SA, Smith SE. Mydriatic drugs for diabetic patients. Br J Ophthalmol. 1985; 69:425–427.
Article
14. Mackool RJ, Muldoon T, Fortier A, Nelson D. Epinephrine-induced cystoid macular edema in aphakic eyes. Arch Ophthalmol. 1977; 95:791–793.
Article
15. Ubuka M, Sugiyama T, Onoda Y, et al. Changes in the blood flow of the optic nerve head induced by different concentrations of epinephrine in intravitreal infusion during vitreous surgery. Invest Ophthalmol Vis Sci. 2014; 55:1625–1629.
Article
16. Labetoulle M, Findl O, Malecaze F, et al. Evaluation of the efficacy and safety of a standardised intracameral combination of mydriatics and anaesthetics for cataract surgery. Br J Ophthalmol. 2016; 100:976–985.
Article